Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MV130 and pneumococcal colonisation in Malawi
PACTR202403820001276Phase 2Completed
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Apr 2024
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of MV130 in Airways Infection (2 arms), sponsored by Liverpool School of Tropical Medicine. Started Apr 2024; status: completed.
02
Drugs
MV130
03
Conditions
Airways Infection
Beyond the preview
Go deeper on PACTR202403820001276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202403820001276.